Medicare Enrolled

Dr. Syed Asad, M.D.

Nuclear Medicine · Jacksonville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
8823 SAN JOSE BLVD STE 209, Jacksonville, FL 32217
9044047044
In practice since 2006 (19 years)
NPI: 1497851042 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Asad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Asad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Asad

Dr. Syed Asad is a nuclear medicine in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Asad performed 13,812 Medicare services across 1,401 unique beneficiaries.

Between the years covered by Open Payments, Dr. Asad received a total of $448,487 from 89 pharmaceutical and/or device companies across 2319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Asad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 32% volume in FL$ $448,487 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,812
Medicare services
Top 32% in FL for nuclear medicine
1,401
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~727 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit11,800$5$7
Office visit, established patient (30-39 min)633$87$473
Office visit, established patient, complex (40-54 min)408$121$543
Needle measurement of electrical activity in arm or leg muscles, complete study222$81$1,523
Office visit, established patient (20-29 min)189$62$404
New patient office visit (45-59 min)126$115$602
Nerve conduction, 11-12 studies115$181$3,488
New patient office visit, complex (60-74 min)107$159$923
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or64$25$364
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face57$113$1,952
Measurement of brain wave activity (eeg), awake and drowsy47$279$6,003
Testing of autonomic (sympathetic) nervous system function18$90$2,691
Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional14$251$3,558
Exam to measure eye deviation and range of motion12$48$1,376
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$448,487
Total received (2018-2024)
Avg $64,070/year across 7 years
Top 4% in FL for nuclear medicine
89
Companies
2,319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$414,403 (92.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,522 (5.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,562 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,519
2023
$40,269
2022
$39,689
2021
$79,349
2020
$17,146
2019
$106,015
2018
$160,501

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Avanir Pharmaceuticals, Inc.
$298,750
Otsuka America Pharmaceutical, Inc.
$32,378
Supernus Pharmaceuticals, Inc.
$30,041
Biohaven Pharmaceuticals, Inc.
$24,576
AbbVie Inc.
$17,001
Novartis Pharmaceuticals Corporation
$7,405
Biohaven Pharmaceutical Holding Company Ltd.
$5,359
ABBVIE INC.
$4,782
Allergan, Inc.
$3,079
Amgen Inc.
$2,897
ARGENX US, INC.
$2,499
Teva Pharmaceuticals USA, Inc.
$1,579
EMD Serono, Inc.
$1,380
Abbott Laboratories
$1,260
Lilly USA, LLC
$950
Medtronic, Inc.
$944
Biogen, Inc.
$920
Alexion Pharmaceuticals, Inc.
$821
Lundbeck LLC
$772
Eisai Inc.
$659
JAZZ PHARMACEUTICALS INC.
$636
GENZYME CORPORATION
$626
Genentech USA, Inc.
$585
CSL Behring
$565
PFIZER INC.
$506
US WorldMeds, LLC
$506
Kyowa Kirin, Inc.
$475
Adamas Pharmaceuticals, Inc.
$402
UCB, Inc.
$352
Allergan Inc.
$346
Boston Scientific Corporation
$343
Medtronic USA, Inc.
$333
Promius Pharma LLC
$277
UPSHER-SMITH LABORATORIES LLC
$260
Neuronetics, Inc.
$254
ACADIA Pharmaceuticals Inc
$236
LivaNova USA, Inc.
$228
Neurelis, Inc.
$228
Neurocrine Biosciences, Inc.
$216
Corium, LLC
$154
EISAI INC.
$154
Celgene Corporation
$126
Janssen Pharmaceuticals, Inc
$123
E.R. Squibb & Sons, L.L.C.
$111
ASSERTIO THERAPEUTICS, Inc.
$110
Mallinckrodt Hospital Products Inc.
$102
Greenwich Biosciences, Inc.
$101
ARBOR PHARMACEUTICALS, INC.
$97
Acorda Therapeutics, Inc
$93
Takeda Pharmaceuticals U.S.A., Inc.
$93
Almatica Pharma LLC
$93
SK Life Science, Inc.
$90
TerSera Therapeutics LLC
$88
Upsher-Smith Laboratories LLC
$88
Grifols USA, LLC
$83
Bausch Health US, LLC
$79
Merz North America, Inc.
$76
Mallinckrodt LLC
$69
Sunovion Pharmaceuticals Inc.
$68
Mallinckrodt Enterprises LLC
$63
MDD US Operations, LLC
$62
Zyla Life Sciences, Inc.
$62
Zyla Life Sciences
$61
CATALYST PHARMACEUTICALS, INC.
$58
GE Healthcare
$56
MITSUBISHI TANABE PHARMA AMERICA, INC.
$53
Mitsubishi Tanabe Pharma America, Inc.
$47
Merz Pharmaceuticals, LLC
$47
Axsome Therapeutics, Inc.
$43
Flowonix Medical Incorporated
$43
Vanda Pharmaceuticals Inc.
$41
Currax Pharmaceuticals LLC
$39
TG Therapeutics, Inc.
$37
Arbor Pharmaceuticals, Inc.
$34
Merck Sharp & Dohme LLC
$34
BOSTON SCIENTIFIC CORPORATION
$31
Egalet US Inc
$30
Impax Laboratories, Inc.
$24
Amneal Pharmaceuticals LLC
$22
Averitas Pharma Inc.
$21
Validus Pharmaceuticals LLC
$21
Marinus Pharmaceuticals, Inc.
$21
Octapharma USA, Inc.
$19
MERZ NORTH AMERICA, INC.
$19
Azurity Pharmaceuticals, Inc.
$18
Vertical Pharmaceuticals, LLC
$17
Assertio Therapeutics, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$12
Pernix Therapeutics Holdings, Inc.
$11
Top 3 companies account for 80.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · BYSTOLIC · Betaseron · Briviact · CONTRAVE · COPAXONE · Cambia · Dayvigo · EMGALITY · EPIDIOLEX · Epidiolex · Equetro · FIRDAPSE · FORTEO · Fycompa · GENERAL DBS · GENERAL - DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Gocovri · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LINZESS · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONZETRA Xsail · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PONVORY · PRIALT · Ponvory · Privigen · Proclaim DRG IPG · Proclaim IPG · Prometra II · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SILENOR · SOLIRIS · SPRAVATO · SPRIX · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS - Sentiva · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTALMY · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nuclear medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for nuclear medicine in FL.

Equivalent to $3,247 per 100 Medicare services performed
Looking for a nuclear medicine in Jacksonville?
Compare nuclear medicines in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse nuclear medicines nearby

Geographic Context

Nuclear Medicines within 10 mi
3
Per 100K population
0.3
County median income
$68,447
Nearest hospital
NH Jacksonville
4.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Asad is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Asad experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Asad performed 11,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Asad receive payments from pharmaceutical companies?
Yes. Dr. Asad received a total of $448,487 from 89 companies across 2,319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Asad's costs compare to other nuclear medicines in Jacksonville?
Dr. Asad's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Asad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →